10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients.

OBJECTIVES We examined VRE colonization, bacteremia (VREB) incidence and outcomes within 100 days of allogeneic hematopoietic cell transplantation (HCT). METHODS HCT recipients screened for VRE were assessed, and colonization and VREB incidence compared over time using linear regression. Cox proportional hazards models were constructed to assess the relationship between mortality, pre-HCT colonization, and underlying disease. RESULTS Of 1492 HCT recipients, 204 (14%) patients were colonized pre-HCT, while 90 (6%) acquired colonization post-HCT. Forty-two patients (2.8%) developed VREB within 100 days post-HCT; the majority, 32 (76%), were previously colonized. The cumulative incidence of VREB was 2.9 per 10,000 patient-days. Over the study period there were no significant changes in incidence of VRE colonization or VREB despite a number of interventions (p > 0.1). Patients with pre-HCT colonization had increased mortality compared to non-colonized patients (HR 2.1; 95% CI: 1.5, 3.3). CONCLUSIONS We found a low burden of VRE at our center with no significant changes observed over a 10-year study period. VRE, while responsible for substantial resource consumption from routine screening and isolation, was an infrequent cause of bacteremia.

[1]  Michael Boeckh,et al.  Reduced mortality after allogeneic hematopoietic-cell transplantation. , 2010, The New England journal of medicine.

[2]  C. Kauffman,et al.  Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes , 2017, Leukemia & lymphoma.

[3]  R. Wenzel,et al.  Contact Precautions for Endemic MRSA and VRE: Time to Retire Legal Mandates. , 2017, JAMA.

[4]  F. Petersen,et al.  Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation , 2017, Infection Control & Hospital Epidemiology.

[5]  S. Weber,et al.  Epidemiology of Vancomycin-Resistant Enterococci Among Patients on an Adult Stem Cell Transplant Unit: Observations From an Active Surveillance Program , 2008, Infection Control & Hospital Epidemiology.

[6]  J. Dipersio,et al.  Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? , 2006, Bone Marrow Transplantation.

[7]  P. Brindley,et al.  Patient Isolation Precautions: Are They Worth It? , 2016, Canadian respiratory journal.

[8]  Herman Goossens,et al.  Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial , 2014, The Lancet. Infectious diseases.

[9]  E. Wong,et al.  Effect of daily chlorhexidine bathing on hospital-acquired infection. , 2013, The New England journal of medicine.

[10]  J. Tarrand,et al.  Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. , 2006, American journal of infection control.

[11]  M. Christner,et al.  Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy. , 2015, International journal of medical microbiology : IJMM.

[12]  H. Sengeløv,et al.  Epidemiology of bloodstream infections after myeloablative and non‐myeloablative allogeneic hematopoietic stem cell transplantation: A single‐center cohort study , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[13]  A. Gasparrini,et al.  Interrupted time series regression for the evaluation of public health interventions: a tutorial , 2016, International journal of epidemiology.

[14]  L. Miller,et al.  Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy , 2015, Epidemiology and Infection.

[15]  K. Thursky,et al.  The prevention and management of infections due to multidrug resistant organisms in haematology patients. , 2015, British journal of clinical pharmacology.

[16]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[17]  S. Pergam,et al.  Unintended Consequences of Pretransplant Vancomycin-Resistant Enterococcus Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients , 2018, Infection Control & Hospital Epidemiology.

[18]  N. Vaughan,et al.  First UK trial of Xenex PX-UV, an automated ultraviolet room decontamination device in a clinical haematology and bone marrow transplantation unit. , 2016, The Journal of hospital infection.

[19]  F. Petersen,et al.  Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  K. van Besien,et al.  The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients , 2014, Leukemia & lymphoma.

[21]  L. Price,et al.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality , 2006, Bone Marrow Transplantation.

[22]  E. Mylonakis,et al.  Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis , 2016, Open forum infectious diseases.

[23]  M. Zervos,et al.  Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. , 2016, Infectious disease clinics of North America.

[24]  Robin Patel,et al.  Vancomycin‐resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia , 2016, Transplant infectious disease : an official journal of the Transplantation Society.

[25]  A. Widmer,et al.  Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS). , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  D. Morgan,et al.  Do contact precautions cause depression? A two-year study at a tertiary care medical centre. , 2011, The Journal of hospital infection.

[27]  J. Mandrekar,et al.  Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients , 2008, Bone Marrow Transplantation.

[28]  J. Lewis,et al.  A single‐center experience with infections due to daptomycin‐nonsusceptible Enterococcus faecium in liver transplant recipients , 2016, Transplant infectious disease : an official journal of the Transplantation Society.

[29]  M. Scheetz,et al.  Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption. , 2017, Diagnostic microbiology and infectious disease.

[30]  Mark A. Miller,et al.  Evaluation of Vancomycin-Resistant Enterococci (VRE)–Associated Morbidity Following Relaxation of VRE Screening and Isolation Precautions in a Tertiary Care Hospital , 2014, Infection Control & Hospital Epidemiology.

[31]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[32]  D. Anderson,et al.  Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study , 2017, The Lancet.

[33]  A. Levin,et al.  Chlorhexidine bathing for the prevention of colonization and infection with multidrug-resistant microorganisms in a hematopoietic stem cell transplantation unit over a 9-year period , 2016, Medicine.

[34]  M. Sorror,et al.  Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  M. Kalaycio,et al.  Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course , 2005, Bone Marrow Transplantation.

[36]  S. L. Kurtz Identification of low, high, and super gelers and barriers to hand hygiene among intensive care unit nurses , 2017, American journal of infection control.

[37]  D. Elashoff,et al.  Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study , 2016, Infection Control & Hospital Epidemiology.

[38]  M. Klein,et al.  Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  G. Zuccotti,et al.  Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[40]  K. Markey,et al.  Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection , 2017, PloS one.

[41]  D. Weisdorf,et al.  Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  A. Cheng,et al.  Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology-oncology patients. , 2013, American journal of infection control.

[43]  C. Schwebel,et al.  Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events , 2013, Intensive Care Medicine.

[44]  Y. Carmeli,et al.  Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.

[45]  P. McCarthy,et al.  Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies , 2016, Infection Control & Hospital Epidemiology.

[46]  J. Buer,et al.  Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation , 2016, Antimicrobial Resistance & Infection Control.

[47]  Carlene A. Muto,et al.  SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.

[48]  G. Papanicolaou,et al.  The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[49]  F. Petersen,et al.  Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[50]  M. Gardam,et al.  Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci , 2016, Infection Control & Hospital Epidemiology.

[51]  Gordon H Bokhart,et al.  Implementation of a Pharmacist-Directed Antimicrobial Stewardship Protocol Utilizing Rapid Diagnostic Testing , 2016, Hospital pharmacy.

[52]  L. Rybicki,et al.  Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation , 2014, Bone Marrow Transplantation.

[53]  Nohemi Sadule-Rios,et al.  Nurses' perceptions of reasons for persistent low rates in hand hygiene compliance. , 2017, Intensive & critical care nursing.